Anxiety, Depression, Digestive System Neoplasm, Lung Neoplasm, Pain, Post-Traumatic Stress Disorder, Psychological Impact of Cancer
Conditions
Brief summary
This randomized pilot clinical trial studies the effects of meditation-based breathing training on patients' control of their breathing patterns and breathing-related movement, as well as on their psychological distress and treatment experience during radiation therapy. Meditation-based breathing training may decrease breathing-related movement and the amount of stress by improving breathing patterns in patients with abdominal or lung cancer undergoing radiation therapy.
Detailed description
PRIMARY OBJECTIVES: I. To evaluate the influence of regular breathing cycles using breathing relaxation techniques on efficacy of the respiratory-gated treatment as measured by: (1) real-time position management (RPM) parameters; (2) end inspiration or expiration length; (3) changes in gate width. SECONDARY OBJECTIVES: I. To evaluate the effect of breathing relaxation techniques on: (1) psychosocial outcomes; (2) treatment compliance. OUTLINE: PHASE I: Patients and staff members complete structured interviews at baseline. PHASE II: Patients are randomized to 1 of 2 arms. ARM I: Patients participate in 3 50-minute breathing training sessions, including a psycho-educational component and meditation-based breathing training, over 10 days. Patients then undergo four dimensional computed tomography (4D-CT) on day 14 and undergo image-guided stereotactic body radiation therapy (SBRT) or standard radiation therapy 5 times a week for up to 5 fractions or 25 fractions, respectively. ARM II: Patients receive standard care over 10 days. Patients then undergo 4D-CT on day 14 and undergo image-guided SBRT or standard radiation therapy 5 times a week for up to 5 fractions or 25 fractions, respectively. After completion of study treatment, patients are followed up at 2 or 5 weeks.
Interventions
Participate in breathing training sessions
Participate in breathing training sessions
Ancillary studies
Sponsors
Study design
Eligibility
Inclusion criteria
* PHASE I - PATIENTS: All patients with abdominal tumors who have undergone at least 4 respiratory-gated radiotherapy treatments * PHASE I - PATIENTS: Full comprehension of English language * PHASE I - STAFF: All staff who have overseen the delivery of respiratory-gated radiotherapy for at least 6 months * PHASE I - STAFF: Full comprehension of English language * PHASE II: All patients with abdominal or lung tumors undergoing a respiratory gating simulation * PHASE II: Karnofsky performance status \> 60% * PHASE II: Life expectancy \> 3 months * PHASE II: No prior radiotherapy to the abdomen/lung * PHASE II: Full comprehension of English language
Exclusion criteria
* PHASE I - PATIENTS: Inability to comprehend English language interview questions * PHASE I - STAFF: Inability to comprehend English language interview questions * PHASE II: Karnofsky performance status \< 60% * PHASE II: Prior radiotherapy to the abdomen/lung * PHASE II: Evidence of progressive or untreated gross disease outside of the abdomen/lung * PHASE II: Inability to comprehend English language breathing exercise instructions * PHASE II: Concurrent diagnosis of a significant respiratory disorder which requires the use of oxygen
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in duty cycle, defined as the fraction of the time of the breathing cycle that the beam is on, before and after breath coaching | Baseline to up to 5 weeks | Data will be analyzed using a mixed-model analysis of variance (ANOVA) to test for differences between the two independent groups (with a fixed effect factor of group membership). |
| Changes in gate width | Baseline to up to 5 weeks | — |
| Changes in the length of the end expiration or end inspiration defined as when the breathing trace or internal motion change direction | Baseline to up to 5 weeks | Data will be analyzed using a mixed-model ANOVA to test for differences between the two independent groups (with a fixed effect factor of group membership). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in patients' self-reported levels of psychological distress, physical pain and discomfort, and post-traumatic stress associated with cancer diagnosis and radiation treatment | Baseline to up to 5 weeks | Data will be analyzed using a mixed-model ANOVA to test for differences between the two independent groups (with a fixed effect factor of group membership). |
Countries
United States